46 reports

Erectile Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022...

  • Dysfunction Drug
  • Pharmaceutical
  • World
  • Smoking Prevalence
  • Stem Cell Transplantation

Erectile Dysfunction (Women’s and Male Health) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Drugs in Development, 2021, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape. Erectile...

  • Pharmaceutical
  • Dysfunction Drug
  • World
  • South Africa
  • Drug Approval
  • Pharmaceutical Registrations

Major players in the erectile dysfunction (ED) drugs market are Eli Lilly and Co., Pfizer, Bayer AG, Dong-A Pharmaceutical Co. Ltd., Vivus, Meda Pharmaceuticals, Apricus Biosciences, Cristália, S.K. Chemicals Co and Teva Pharmaceutical Industries Ltd. The global drugs for erectile dysfunction market is expected to grow from $3.09 billion...

  • Dysfunction Drug
  • World
  • Europe
  • Middle East
  • APAC
  • United Kingdom
  • Chronic Disease Prevalence

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Erectile Dysfunction Market Report The global erectile dysfunction is expected to cross USD 4.7 billion during the period 2021-2026. The global erectile dysfunction market is expected to observe a negative growth during the forecast...

  • Dysfunction Drug
  • World
  • Smoking Prevalence
  • Diabetes Prevalence

Erectile Dysfunction Drugs market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Erectile Dysfunction Drugs Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Erectile Dysfunction Drugs types, applications....

  • Dysfunction Drug
  • World

Erectile Dysfunction (ED) Drugs Market – Scope of Report This report on the global erectile dysfunction (ED) drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028.The report provides revenue...

  • Dysfunction Drug
  • World

Erectile Dysfunction Shockwave Generators market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Erectile Dysfunction Shockwave Generators Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Erectile Dysfunction...

  • Dysfunction Drug
  • World

Erectile Dysfunction - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Pipeline Review, H2 2020, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape. Erectile dysfunction, or ED, is...

  • Dysfunction Drug
  • World
  • South Africa
  • Pharmaceutical Registrations
  • Drug Approval

Major players in the erectile dysfunction (ED) drugs market are Eli Lilly and Co., Pfizer, Bayer AG, Dong-A Pharmaceutical Co. Ltd and Vivus. The global drugs for erectile dysfunction market is expected to grow from $3.76 billion in 2020 to $4.99 billion in 2021 at a compound annual growth rate (CAGR) of 32.7%. The growth is mainly...

  • Dysfunction Drug
  • World
  • Europe
  • United Kingdom
  • Chronic Disease Prevalence

Erectile Dysfunction Drugs Market Report Overview Erectile Dysfunction Drugs market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Erectile Dysfunction Drugs market types and applications. It is a focused study on Erectile Dysfunction Drugs...

  • Dysfunction Drug
  • World
  • Health Provider Density

Female Sexual Dysfunction (Women’s and Male Health) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Female Sexual Dysfunction – Drugs In Development, 2021, provides an overview of the Female Sexual Dysfunction (Women’s Health) pipeline landscape. Female...

  • Dysfunction Drug
  • Drug Development
  • World
  • Depression Prevalence
  • Drug Approval

Drugs For Erectile Dysfunction Global Market Report 2020-30: Covid 19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global drugs for erectile dysfunction market as it emerges from the Covid 19 shut down. Description: Where is the largest...

  • Dysfunction Drug
  • World

Global Erectile Dysfunction (ED) Drugs Market 2022-2026 The analyst has been monitoring the erectile dysfunction (ED) drugs market and it is poised to grow by $ 1.20 bn during 2022-2026, progressing at a CAGR of 6.1% during the forecast period. Our report on the erectile dysfunction (ED) drugs market provides a holistic...

  • Dysfunction Drug
  • World
  • Chronic Disease Prevalence

Erectile Dysfunction - Pipeline Review, H1 2020 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Pipeline Review, H1 2020, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape. Erectile dysfunction, or ED, is the...

  • Dysfunction Drug
  • World
  • South Africa
  • Pharmaceutical Registrations
  • Drug Approval

Female Sexual Dysfunction - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Female Sexual Dysfunction - Pipeline Review, H1 2020, provides an overview of the Female Sexual Dysfunction (Women’s Health) pipeline landscape. Female sexual...

  • Dysfunction Drug
  • World
  • Depression Prevalence
  • Drug Approval

Report Scope: The report focuses on newer shockwave devices and innovations in frequency length, as well as devices that have been recently launched or are in development.This report will also highlight the current and future market potentiality of shockwave therapy, with detailed analysis of competitive environment between...

  • Dysfunction Drug
  • World

Major companies in the genito-urinary drugs market include Daiichi Sankyo Company; Pfizer Inc; Bayer AG; Astellas Pharma Inc and Allergan Plc. The global genito-urinary drugs market is expected to grow from $49.24 billion in 2020 to $53.78 billion in 2021 at a compound annual growth rate (CAGR) of 9.2%. The growth is mainly due to the...

  • Pharmaceutical
  • Incontinence Product
  • Genitourinary System Disease
  • Dysfunction Drug
  • World
  • Health Expenditure
  • Population Over Age Of 65

The global genitourinary drugs market is expected to grow at a CAGR of around 4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. The...

  • Therapy
  • Research And Development
  • Genitourinary System Disease
  • Clinical Trial
  • Dysfunction Drug
  • Hormone
  • Prostate Cancer
  • World

Female Sexual Dysfunction - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Female Sexual Dysfunction - Pipeline Review, H2 2019, provides an overview of the Female Sexual Dysfunction (Women’s Health) pipeline landscape. Female sexual...

  • Dysfunction Drug
  • World
  • Depression Prevalence
  • Drug Approval

Global Phosphodiesterase (PDE) Inhibitors Market 2022-2026 The analyst has been monitoring the phosphodiesterase (PDE) inhibitors market and it is poised to grow by $ 2.86 bn during 2022-2026, accelerating at a CAGR of 5.81% during the forecast period. Our report on the phosphodiesterase (PDE) inhibitors market provides...

  • Dysfunction Drug
  • Marketing Research
  • Chronic Disease
  • World

High levels of pipeline activity are being observed in Left Ventricular Dysfunction treatment during 2019. Clinical development activities are being undertaken by more than 5 companies including Armaron Bio Pty Ltd., Bayer AG, Innopharmax Inc., Mesoblast Ltd, Quantum Genomics Corp. and others. A Significant contribution to the Left...

  • Drug Development
  • Therapy
  • Clinical Trial
  • Dysfunction Drug
  • World
  • Drug Approval

The ongoing clinical trial research report- “2019 Erectile Dysfunction Ongoing Clinical Trials Study” analyzes the current scenario of all active Erectile Dysfunction trials across the world. The report presents top level analysis of global Erectile Dysfunction clinical trials across countries, companies and universities. It is designed to...

  • Dysfunction Drug
  • Clinical Trial
  • World
  • APAC

This study covers the world outlook for erectile dysfunction drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Dysfunction Drug
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for erectile dysfunction therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Dysfunction Drug
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for sexual dysfunction drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Dysfunction Drug
  • World
  • Gross Domestic Product
  • Disposable Income

The global clinical trial report- “2019 Erectile Dysfunction Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Erectile Dysfunction. It presents in-depth analysis of Erectile Dysfunction clinical trials across markets and companies. The research work is for providing complete understanding into trends...

  • Dysfunction Drug
  • Clinical Trial
  • World

Summary Erectile Dysfunction pipeline research report is a part of our 300+ Pharmaceutical and Healthcare disease pipeline report series. It provides detailed insights into constipation R&D activities including pipeline candidates, grants, developments, investments, technological advancements, and progress. Extensive...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • Dysfunction Drug

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Erectile Dysfunction Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Erectile Dysfunction pipeline products. The Erectile Dysfunction pipeline guide presents complete overview of drugs currently...

  • Dysfunction Drug
  • World

Erectile Dysfunction (ED) Drugs Market - Overview This report studies the current as well as future prospects of the global erectile dysfunction (ED) drugs market.Stakeholders of the market include companies and intermediaries engaged in the manufacture, commercialization, and marketing of therapeutic drugs for the treatment of erectile...

  • Dysfunction Drug
  • World

Erectile Dysfunction ongoing clinical trials report provides comprehensive analysis and trends in global Erectile Dysfunction disease clinical trials. The research work analyzes the ongoing Erectile Dysfunction clinical trial trends across countries and companies. The report focuses on drugs and therapies being evaluated for Erectile...

  • Clinical Trial
  • Dysfunction Drug
  • World